---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-008137"
form_type: "8-K"
ticker: null
cik: "0001629205"
company_name: "Innovation1 Biotech Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T15:35:09.466680+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Innovation1 Biotech issues $20,000 promissory note at 10% interest

## Summary
- Issued $20,000 demand promissory note to an accredited investor on Nov 1, 2023.
- Note bears 10% annual interest; matures Jan 30, 2024 or 5 days after demand.
- Proceeds used for general working capital; no other terms disclosed.

## SEC filing metadata
- accession: 0001477932-23-008137
- form_type: 8-K
- cik: 0001629205
- company_name: Innovation1 Biotech Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1629205/000147793223008137/0001477932-23-008137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1629205/000147793223008137/ivbt_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-008137
- JSON: https://secwatch.observer/filing/0001477932-23-008137.json
- Plain text: https://secwatch.observer/filing/0001477932-23-008137.txt

## Key facts
- Debt Financings
  Innovation1 Biotech Inc. incurred loan of $20,000 at 10% interest per annum maturing January 30, 2024.
  - Instrument: loan
  - Principal: $20,000
  - Rate: 10% interest per annum
  - Maturity: January 30, 2024
  - Event: incurrence
  source text: On November 1, 2023, Innovation1 Biotech Inc. (the “Company”) issued a $20,000 Demand Promissory Note (the “Note”) to an accredited investor in consideration for $20,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1629205/000147793223008137/0001477932-23-008137-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.